Risk of hepatocellular carcinoma after DAA treatment in cirrhotic HIV-HCV-coinfected patients: where do we stand?
Sign Up to like & getrecommendations! Published in 2018 at "AIDS"
DOI: 10.1097/qad.0000000000001823
Abstract: Together with the increase in life expectancy of HIVinfected individuals with antiretroviral therapy (ART), morbidity and mortality from liver disease has sharply increased in individuals coinfected with hepatitis C or B and exhibit advanced liver… read more here.
Keywords: hepatocellular carcinoma; carcinoma; treatment cirrhotic; risk hepatocellular ... See more keywords